Pengqi Wang

Pengqi Wang

Auto-generated profile, based on publicly available information

Pengqi Wang

New Cornerstone Science Laboratory, School of Pharmaceutical Sciences Tsinghua University Beijing 100084 China

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 June 2025 in Science
Verified
Journal Article
Closed access
YZYing Zhang
Ying Zhang
LTLu Tian
Lu Tian
GHGaoxingyu Huang
Gaoxingyu Huang
XGXiaofei Ge
Xiaofei Ge
FKFang Kong
Fang Kong
YSYigong Shi
Yigong Shi
During apoptosis, cytosolic BAX monomers are translocated to the mitochondria to permeabilize the outer membrane. Here, we identified a dimer of BAX dimers as the basic repeating unit of its various oligomeric forms: arcs, lines, and rings. Cryo–electron microscopy structure of the BAX repeating unit at 3.2-angstrom resolution revealed the interactions within and between dimers. End-to-end stacking of the repeating units through the protruding α9 pairs yielded lines, arcs, polygons, and rings. We structurally characterized the tetragon, pentagon, hexagon, and heptagon, which comprise 16, 20, 24, and 28 BAX protomers, respectively. Missense mutations at the BAX inter-protomer interface damage pore formation and cripple its proapoptotic function. The assembly principle of the various BAX oligomers reported here provides the structural basis of membrane permeabilization by BAX.

27 September 2024 in Trends in Biotechnology
Verified
Journal Article
Closed access
KHKezhang He
Kezhang He
QXQiaomei Xue
Qiaomei Xue
WZWei Zhou
Wei Zhou
PWPengqi Wang
Pengqi Wang
XHXiaodan Hu
Xiaodan Hu
SDSheng Ding
Sheng Ding

11 November 2025 in Advanced Science
Verified
Journal Article
Open access
PWPengqi Wang
Pengqi Wang
KHKezhang He
Kezhang He
BWBowen Wang
Bowen Wang
WZWei Zhou
Wei Zhou
YZYing Zhang
Ying Zhang
SDSheng Ding
Sheng Ding
Ferroptosis presents great potential for cancer therapy, either alone or in combination with classical therapy. However, inducing ferroptosis by targeting canonical ferroptosis suppressors that directly inhibit lipid peroxidation non‐selectively induces ferroptosis in both cancerous and normal cells, thereby limiting its therapeutic potential. In this study, it is revealed that aldolase A (ALDOA) reprograms lipid metabolism to resist ferroptosis in cancer cells and identifies ALDOA as a targetable vulnerability for ferroptosis sensitization. Cancer cells with ALDOA suppression exhibit increased susceptibility to ferroptosis—a response less obvious in normal cells. Mechanistically, ALDOA depletion induces significant accumulation of fructose 1,6‐bisphosphate in cancer cells, thereby enhancing autophagy‐dependent degradation of phospholipid‐modifying enzymes. These alterations increase the ratio of phospholipids containing pro‐ferroptotic polyunsaturated fatty acids over anti‐ferroptotic monounsaturated fatty acids, culminating in heightened ferroptosis sensitivity. Moreover, ALDOA inhibitors selectively promote ferroptosis in cancer cells, both in vitro and in vivo. Collectively, the findings reveal that ALDOA‐mediated metabolic reprogramming is a targetable vulnerability for ferroptosis sensitization in cancer.